{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:51:09Z","timestamp":1789041069534,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bcp.2025.117113","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T02:42:19Z","timestamp":1751683339000},"page":"117113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["GPR55: Physiological functions and therapeutic potential in depression"],"prefix":"10.1016","volume":"240","author":[{"given":"Yang","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7967-3456","authenticated-orcid":false,"given":"Wei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117113_b0005","unstructured":".H. Organization, World Health Organization. The Global Burden of Disease: 2004 Update, (2008)."},{"key":"10.1016\/j.bcp.2025.117113_b0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nyas.12223","article-title":"New paradigms for treatment-resistant depression","volume":"1292","author":"Zarate","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/bec.2019.4","article-title":"The classification and explanation of depression","volume":"36","author":"Clack","year":"2019","journal-title":"Behav. Chang."},{"key":"10.1016\/j.bcp.2025.117113_b0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2024.01.010","article-title":"Bavachin ameliorates neuroinflammation and depressive-like behaviors in streptozotocin-induced diabetic mice through the inhibition of PKC\u03b4","volume":"213","author":"Zhang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2025.117113_b0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-psych-122216-011613","article-title":"Depression's Unholy Trinity: dysregulated stress, Immunity, and the Microbiome","volume":"71","author":"Cruz-Pereira","year":"2020","journal-title":"Annu. Rev. Psychol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117113_b0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1176\/ajp.156.6.837","article-title":"Causal relationship between stressful life events and the onset of major depression","volume":"156","author":"Kendler","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117113_b0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2023.06.004","article-title":"Sodium aescinate improve behavioral performance by inhibiting dorsal raphe nucleus NLRP3 inflammasome in Post-traumatic stress disorder Rat Model","volume":"671","author":"Mei","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2025.117113_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112493","article-title":"Psoralen protects neurons and alleviates neuroinflammation by regulating microglial M1\/M2 polarization via inhibition of the Fyn-PKC\u03b4 pathway","volume":"137","author":"Guo","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2025.117113_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102996","article-title":"Phosphatidate phosphatase Lipin1 involves in diabetic encephalopathy pathogenesis via regulating synaptic mitochondrial dynamics","volume":"69","author":"Han","year":"2024","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117113_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091921","article-title":"The role of the microbiome-brain-gut axis in the pathogenesis of depressive disorder","volume":"14","author":"M\u0142ynarska","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2025.117113_b0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jad.2023.01.122","article-title":"High-cholesterol diet promotes depression- and anxiety-like behaviors in mice by impact gut microbe and neuroinflammation","volume":"327","author":"Zou","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.bcp.2025.117113_b0060","article-title":"Uncovering a causal connection between gut microbiota and six thyroid diseases: a two-sample mendelian randomization study","volume":"13","author":"Chen","year":"2024","journal-title":"Biology (basel)"},{"issue":"4","key":"10.1016\/j.bcp.2025.117113_b0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jamapsychiatry.2013.4291","article-title":"Epigenetic mechanisms of depression","volume":"71","author":"Nestler","year":"2014","journal-title":"JAMA Psychiat."},{"issue":"11","key":"10.1016\/j.bcp.2025.117113_b0070","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.bcp.2025.117113_b0075","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0080","article-title":"The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma","volume":"18","author":"Wan","year":"2023","journal-title":"Open Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117113_b0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(98)00277-0","article-title":"Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain","volume":"64","author":"Sawzdargo","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2008.04.006","article-title":"The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain","volume":"139","author":"Staton","year":"2008","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.bcp.2025.117113_b0095","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117113_b0100","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.febslet.2009.05.028","article-title":"Differential changes in GPR55 during microglial cell activation","volume":"583","author":"Pietr","year":"2009","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.bcp.2025.117113_b0105","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/me.2011-1197","article-title":"Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55","volume":"25","author":"Henstridge","year":"2011","journal-title":"Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117113_b0110","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jb\/mvp208","article-title":"Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells","volume":"147","author":"Oka","year":"2010","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00418-015-1321-7","article-title":"A role for GPR55 in human placental venous endothelial cells","volume":"144","author":"Kremshofer","year":"2015","journal-title":"Histochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117113_b0120","article-title":"GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bcp.2025.117113_b0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/fcp.12099","article-title":"Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats","volume":"29","author":"Rahimi","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21307\/ane-2018-001","article-title":"Possible role of hippocampal GPR55 in spatial learning and memory in rats","volume":"78","author":"Marichal-Cancino","year":"2018","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.bcp.2025.117113_b0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1749-6632.2000.tb06554.x","article-title":"Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses","volume":"905","author":"Xiao","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2025.117113_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113248","article-title":"GPR55 in the brain and chronic neuropathic pain","volume":"406","author":"Armin","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0145","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12974-018-1362-7","article-title":"Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells","volume":"15","author":"Saliba","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12964-021-00727-w","article-title":"Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning","volume":"19","author":"Mosca","year":"2021","journal-title":"Cell Commun. Signal"},{"issue":"6","key":"10.1016\/j.bcp.2025.117113_b0155","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.coph.2012.09.009","article-title":"A potential role for GPR55 in gastrointestinal functions","volume":"12","author":"Schicho","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2025.117113_b0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2013.09.039","article-title":"Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats","volume":"721","author":"Marichal-Cancino","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117113_b0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117113_b0170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ptr.3375","article-title":"Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation","volume":"25","author":"Farrimond","year":"2011","journal-title":"Phytother. Res."},{"issue":"7","key":"10.1016\/j.bcp.2025.117113_b0175","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bcp.2025.117113_b0180","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/labinvest.2011.62","article-title":"Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor","volume":"91","author":"Huang","year":"2011","journal-title":"Lab. Invest."},{"issue":"43","key":"10.1016\/j.bcp.2025.117113_b0185","doi-asserted-by":"crossref","first-page":"29817","DOI":"10.1074\/jbc.M109.050187","article-title":"Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands","volume":"284","author":"Kapur","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117113_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105743","article-title":"The neuroprotective effects of GPR55 against hippocampal neuroinflammation and impaired adult neurogenesis in CSDS mice","volume":"169","author":"Shen","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2025.117113_b0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-319-41523-9_3","article-title":"7TM domain structure of adhesion GPCRs","volume":"234","author":"de Graaf","year":"2016","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117113_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2017.02.004","article-title":"The G protein-coupled receptor N-terminus and receptor signalling: N-tering a new era","volume":"33","author":"Coleman","year":"2017","journal-title":"Cell. Signal."},{"issue":"32","key":"10.1016\/j.bcp.2025.117113_b0205","doi-asserted-by":"crossref","first-page":"8434","DOI":"10.1021\/bi8004126","article-title":"Functional and biophysical analysis of the C-terminus of the CGRP-receptor; a family B GPCR","volume":"47","author":"Conner","year":"2008","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.bcp.2025.117113_b0210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00726-010-0616-1","article-title":"Two intracellular helices of G-protein coupling receptors could generally support oligomerization and coupling with transducers","volume":"40","author":"Parker","year":"2011","journal-title":"Amino Acids"},{"issue":"5","key":"10.1016\/j.bcp.2025.117113_b0215","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjp.0707419","article-title":"The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects","volume":"152","author":"Johns","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1074\/jbc.M111.296020","article-title":"Modulation of L-\u03b1-lysophosphatidylinositol\/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids","volume":"287","author":"Anavi-Goffer","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2025.117113_b0225","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bbalip.2010.03.012","article-title":"Generation of lysophosphatidylinositol by DDHD domain containing 1 (DDHD1): possible involvement of phospholipase D\/phosphatidic acid in the activation of DDHD1","volume":"1801","author":"Yamashita","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.bcp.2025.117113_b0230","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bbrc.2007.08.078","article-title":"Identification of GPR55 as a lysophosphatidylinositol receptor","volume":"362","author":"Oka","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2025.117113_b0235","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0240","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/jpet.113.204180","article-title":"A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function","volume":"346","author":"Kargl","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2025.117113_b0245","series-title":"Screening for selective ligands for GPR55 antagonists in Probe Reports from the NIH Molecular Libraries Program (internet)","author":"Heynen-Genel","year":"2010"},{"issue":"2","key":"10.1016\/j.bcp.2025.117113_b0250","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/onc.2010.417","article-title":"The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation","volume":"30","author":"Pi\u00f1eiro","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1096\/fj.08-108670","article-title":"The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation","volume":"23","author":"Henstridge","year":"2009","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.bcp.2025.117113_b0260","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1476-5381.2009.00625.x","article-title":"GPR55 ligands promote receptor coupling to multiple signalling pathways","volume":"160","author":"Henstridge","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117113_b0265","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.drudis.2013.12.005","article-title":"A potential role for GPR55 in the regulation of energy homeostasis","volume":"19","author":"Simcocks","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2005.11.003","article-title":"In silico patent searching reveals a new cannabinoid receptor","volume":"27","author":"Baker","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2025.117113_b0275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2014.06.007","article-title":"GPR55: from orphan to metabolic regulator?","volume":"145","author":"Liu","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yhbeh.2014.05.001","article-title":"Guest editor's introduction: energy homeostasis in context","volume":"66","author":"Schneider","year":"2014","journal-title":"Horm. Behav."},{"issue":"2","key":"10.1016\/j.bcp.2025.117113_b0285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/syn.20821","article-title":"Functional polymorphism in the GPR55 gene is associated with anorexia nervosa","volume":"65","author":"Ishiguro","year":"2011","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.bcp.2025.117113_b0290","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1463-1326.2011.01515.x","article-title":"The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats","volume":"14","author":"D\u00edaz-Arteaga","year":"2012","journal-title":"Diabetes Obes. Metab."},{"issue":"3","key":"10.1016\/j.bcp.2025.117113_b0295","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ijo.2015.209","article-title":"Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity","volume":"40","author":"Meadows","year":"2016","journal-title":"Int. J. Obes. (Lond)"},{"issue":"12","key":"10.1016\/j.bcp.2025.117113_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167965","article-title":"Deletion of Gpr55 results in subtle effects on energy metabolism, motor activity and thermal pain sensation","volume":"11","author":"Bjursell","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2025.117113_b0305","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tips.2008.12.004","article-title":"The enigmatic pharmacology of GPR55","volume":"30","author":"Ross","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2025.117113_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173340","article-title":"Activation of GPR55 attenuates cognitive impairment, oxidative stress, neuroinflammation, and synaptic dysfunction in a streptozotocin-induced Alzheimer's mouse model","volume":"214","author":"Xiang","year":"2022","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.bcp.2025.117113_b0315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbi.2018.11.017","article-title":"Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation","volume":"76","author":"Hill","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.bcp.2025.117113_b0320","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1038\/s41380-024-02614-5","article-title":"Modulation of neuroinflammation and oxidative stress by targeting GPR55 - new approaches in the treatment of psychiatric disorders","volume":"29","author":"Apweiler","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bcp.2025.117113_b0325","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s13311-018-0610-y","article-title":"Alterations in gene and protein expression of cannabinoid CB(2) and GPR55 receptors in the dorsolateral prefrontal cortex of suicide victims","volume":"15","author":"Garc\u00eda-Guti\u00e9rrez","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.bcp.2025.117113_b0330","doi-asserted-by":"crossref","first-page":"e1640","DOI":"10.1371\/journal.pone.0001640","article-title":"Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects","volume":"3","author":"Onaivi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117113_b0335","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"13","key":"10.1016\/j.bcp.2025.117113_b0340","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1073\/pnas.1211204110","article-title":"Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses","volume":"110","author":"Sylantyev","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117113_b0345","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1192\/S0007125000291733","article-title":"Serotonergic dysfunction in depression","volume":"8","author":"Meltzer","year":"1989","journal-title":"Br. J. Psychiatry Suppl."},{"issue":"20","key":"10.1016\/j.bcp.2025.117113_b0350","doi-asserted-by":"crossref","first-page":"21838","DOI":"10.1021\/acsomega.3c08934","article-title":"Activation of GPR55 ameliorates maternal separation-induced learning and memory deficits by augmenting 5-HT synthesis in the dorsal raphe nucleus of juvenile mice","volume":"9","author":"Sun","year":"2024","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0355","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neubiorev.2006.05.003","article-title":"Effects of repeated maternal separation on anxiety- and depression-related phenotypes in different mouse strains","volume":"31","author":"Millstein","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bcp.2025.117113_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108599","article-title":"N-3 PUFA improved post-menopausal depression induced by maternal separation and chronic mild stress through serotonergic pathway in rats-effect associated with lipid mediators","volume":"91","author":"Choi","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bcp.2025.117113_b0365","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbi.2020.07.037","article-title":"Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors","volume":"89","author":"Mazza","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2025.117113_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122724","article-title":"Cell-liposome delivery system based on neuroinflammation to target the amygdala for ameliorating depressive-like behaviors","volume":"637","author":"Zhou","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bcp.2025.117113_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110552","article-title":"Upregulation of A20 and TAX1BP1 contributes to the anti-neuroinflammatory and antidepressant effects of bavachalcone","volume":"122","author":"Wu","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117113_b0380","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/ibd.21538","article-title":"The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment","volume":"17","author":"Schicho","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bcp.2025.117113_b0385","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3389\/fphar.2020.01002","article-title":"O-1602, an agonist of atypical cannabinoid receptors GPR55, reverses the symptoms of depression and detrusor overactivity in rats subjected to corticosterone treatment","volume":"11","author":"Wr\u00f3bel","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117113_b0390","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/glia.22560","article-title":"The G protein-coupled receptor 55 ligand l-\u03b1-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion","volume":"61","author":"Kallendrusch","year":"2013","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.bcp.2025.117113_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020959","article-title":"Functional selectivity of coumarin derivates acting via GPR55 in neuroinflammation","volume":"23","author":"Apweiler","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2025.117113_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/ph17060674","article-title":"Anti-inflammatory effects of GPR55 agonists and antagonists in LPS-treated Bv2 microglial cells","volume":"17","author":"Sun","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.bcp.2025.117113_b0405","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WNR.0000000000001601","article-title":"Region-specific dysregulation of endocannabinoid system in learned helplessness model of depression","volume":"32","author":"Huang","year":"2021","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.bcp.2025.117113_b0410","first-page":"S51","article-title":"Major depression among methamphetamine users entering drug treatment programs","volume":"195","author":"McKetin","year":"2011","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.bcp.2025.117113_b0415","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jad.2017.06.017","article-title":"Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal","volume":"221","author":"Ren","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.bcp.2025.117113_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30462","article-title":"GPR55 activation improves anxiety- and depression-like behaviors of mice during methamphetamine withdrawal","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"issue":"34","key":"10.1016\/j.bcp.2025.117113_b0425","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300585120","article-title":"Synaptic and cellular endocannabinoid signaling mechanisms regulate stress-induced plasticity of nucleus accumbens somatostatin neurons","volume":"120","author":"Kondev","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.bcp.2025.117113_b0430","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hipo.22747","article-title":"A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity","volume":"27","author":"Hurst","year":"2017","journal-title":"Hippocampus"},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0435","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","article-title":"LTP and LTD: an embarrassment of riches","volume":"44","author":"Malenka","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2025.117113_b0440","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0079-6123(07)00008-8","article-title":"Synaptic plasticity in learning and memory: stress effects in the hippocampus","volume":"169","author":"Howland","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"12","key":"10.1016\/j.bcp.2025.117113_b0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206986","article-title":"T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117113_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110153","article-title":"Neuromolecular and behavioral effects of cannabidiol on depressive-associated behaviors and neuropathic pain conditions in mice","volume":"261","author":"Shen","year":"2024","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0455","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1038\/s41467-020-19780-z","article-title":"Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice","volume":"11","author":"Xu","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2025.117113_b0460","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jpain.2017.12.002","article-title":"The involvement of the endocannabinoid system in the peripheral antinociceptive action of ketamine","volume":"19","author":"Ferreira","year":"2018","journal-title":"J. Pain"},{"key":"10.1016\/j.bcp.2025.117113_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107545","article-title":"Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression","volume":"211","author":"Silva","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0470","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12974-021-02377-8","article-title":"Innate immune stimulation by monophosphoryl lipid a prevents chronic social defeat stress-induced anxiety-like behaviors in mice","volume":"19","author":"Li","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.bcp.2025.117113_b0475","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12264-010-0323-7","article-title":"Behavioral animal models of depression","volume":"26","author":"Yan","year":"2010","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bcp.2025.117113_b0480","doi-asserted-by":"crossref","unstructured":"B. Vollmayr, H. Faust, S. Lewicka, F.A. Henn, Brain-derived-neurotrophic-factor (BDNF) stress response in rats bred for learned helplessness, Mol Psychiatry 6(4) (2001) 471-4, 358.","DOI":"10.1038\/sj.mp.4000907"},{"issue":"4","key":"10.1016\/j.bcp.2025.117113_b0485","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.neuroscience.2006.11.007","article-title":"Learned helplessness is independent of levels of brain-derived neurotrophic factor in the hippocampus","volume":"144","author":"Greenwood","year":"2007","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.bcp.2025.117113_b0490","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/187152412802430156","article-title":"The atypical cannabinoid O-1602: targets, actions, and the central nervous system","volume":"12","author":"Ashton","year":"2012","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.bcp.2025.117113_b0495","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jbior.2015.10.003","article-title":"Role of the lysophosphatidylinositol\/GPR55 axis in cancer","volume":"60","author":"Falasca","year":"2016","journal-title":"Adv. Biol. Regul."},{"issue":"3","key":"10.1016\/j.bcp.2025.117113_b0500","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/aps.2017.157","article-title":"The LPI\/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling","volume":"39","author":"Zhou","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0505","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bph.13345","article-title":"GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis","volume":"173","author":"Kargl","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117113_b0510","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.2042-7158.2011.01250.x","article-title":"A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells","volume":"63","author":"Chiba","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"issue":"38","key":"10.1016\/j.bcp.2025.117113_b0515","doi-asserted-by":"crossref","first-page":"16511","DOI":"10.1073\/pnas.0902743106","article-title":"The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo","volume":"106","author":"Whyte","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0520","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2011.06.004","article-title":"The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55","volume":"500","author":"Schuelert","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"24","key":"10.1016\/j.bcp.2025.117113_b0525","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413328","article-title":"Gene expression data mining reveals the involvement of GPR55 and its endogenous ligands in immune response, cancer, and differentiation","volume":"22","author":"Wnorowski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117113_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136218","article-title":"Blockade of GPR55 in dorsal periaqueductal gray produces anxiety-like behaviors and evocates defensive aggressive responses in alcohol-pre-exposed rats","volume":"764","author":"V\u00e1zquez-Le\u00f3n","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2025.117113_b0535","unstructured":"S. Heynen-Genel, R. Dahl, S. Shi, L. Milan, S. Hariharan, Y. Bravo, E. Sergienko, M. Hedrick, S. Dad, D. Stonich, Screening for selective ligands for GPR55-agonists, Probe reports from the NIH molecular libraries program [internet] (2011)."},{"issue":"1","key":"10.1016\/j.bcp.2025.117113_b0540","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.110.172650","article-title":"Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist","volume":"337","author":"Brown","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225003788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225003788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T21:07:50Z","timestamp":1755810470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225003788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":108,"alternative-id":["S0006295225003788"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117113","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPR55: Physiological functions and therapeutic potential in depression","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117113"}}